Latest AI and machine learning research in acute coronary syndrome for healthcare professionals.
Cardiovascular disease (CVD) remains the leading cause of mortality worldwide despite major advances in pharmacotherapy. Emerging evidence reveals a pivotal role for the gut-heart axis, wherein gut microbiota are and their metabolites influence CV physiology, pathology, and drug responsiveness. Dysbiosis in conditions such as hypertension, atherosclerosis, and heart failure has been associated wit...
The validation of promising clinical biomarkers, molecular mechanisms, and novel drug targets in cardiovascular disease (CVD) is hindered by a vast and fragmented biomedical literature, which now exceeds 38 million publications indexed in PubMed. To address the central challenge of navigating and synthesizing a huge fragmented biomedical literature base, we applied our validated machine learning-b...
OBJECTIVE: Acute coronary syndrome (ACS) is a life-threatening condition requiring accurate diagnosis for better outcomes. However, variability in sig...
BACKGROUND: Type 2 diabetes mellitus (T2DM) substantially increases the risk of macrovascular complications, including coronary artery disease, cerebr...
The prediction of hospital length of stay (LOS) is of great significance for hospitals to rationally allocate medical resources and provide timely tre...
PURPOSE: Accurate evaluation of left ventricular (LV) dysfunction and infarct localization in acute myocardial infarction (AMI) remains challenging du...
BACKGROUND: Acute myocardial infarction (AMI) presents a critical clinical challenge due to its rapid progression and high mortality, compounded by di...
Objective: To develop and validate a deep learning model based on retinal fundus images for predicting the risk of long-term adverse cardiovascular ev...
Timely and sensitive detection of cardiac troponin I (cTnI) is critical for early diagnosis of myocardial infarction, particularly at the point-of-car...
OBJECTIVE: Atrial fibrillation in elderly patients increases the risk of thromboembolism, necessitating long-term anticoagulation. While non-vitamin K...
Timely diagnosis of non-ST-elevation myocardial infarction (NSTEMI) remains challenging, as current protocols rely on serial high-sensitivity cardiac ...
PURPOSE: Patients with Autoimmune Neurological Disorders (ANDs) require routine immunomodulatory therapy, which inherently increases thrombosis risk. ...
INTRODUCTION: Blood transfusion in patients undergoing surgical resection for pancreatic ductal adenocarcinoma (PDAC) is associated with worse outcome...
BACKGROUND: Beyond their classical roles in haemostasis and thrombosis, platelets have been recognised as active regulators of immune responses. Howev...
BACKGROUND: With the availability of newer therapies, the duration of therapy (DoT) shortens with each increasing line of treatment in Japanese patien...
Cardiac tamponade is a rare yet catastrophic complication during atrial fibrillation (AF) catheter ablation. Influenced by multiple procedural and pat...
BackgroundThis study aimed to develop multiple machine learning (ML) models to predict DVT stability based on clinical and computed tomography (CT) te...
Rhabdomyolysis is a severe condition with high morbidity and mortality, driven by complications like acute kidney injury. Early risk stratification re...
Heart failure (HF) is one of the major causes of morbidity and mortality globally, necessitating accurate tools for health outcome prediction and risk...
OBJECTIVE: Sepsis-associated liver injury (SALI) occurs in approximately 40% of sepsis cases and is linked to high mortality, a challenge that may ste...